Emergent BioSolutions, Inc. (EBS)
8.15
+0.09
(+1.12%)
USD |
NYSE |
May 20, 16:00
8.10
-0.05
(-0.61%)
After-Hours: 20:00
Emergent BioSolutions EPS Diluted (Quarterly) : 0.0743 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.80M |
| Revenue (Quarterly) | 156.10M |
| Total Expenses (Quarterly) | 149.30M |
| Enterprise Value | 889.37M |
| Gross Profit Margin (Quarterly) | 43.31% |
| Profit Margin (Quarterly) | 4.36% |
| Earnings Yield | -3.47% |
| Operating Earnings Yield | 15.91% |
| Normalized Earnings Yield | -0.8442 |